We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > PLx Pharma

News List

PLx Pharma Submits sNDAs for VAZALORE americanpharmaceuticalreview
November 26, 2020
PLx Pharma announced two chemistry and manufacturing control (CMC) supplemental New Drug Applications (sNDAs), one for VAZALORE 325 mg and one for VAZALORE 81 mg dose (referred to together as VAZALORE), have been submitted to the U.S. Food and Drug ...
PLx Pharma and Dipexium Pharmaceuticals Complete Merger americanpharmaceuticalreview
April 24, 2017
PLx Pharma Inc. completed its previously announced merger with Dipexium Pharmaceuticals, Inc. effective April 19, 2017. The combined company, PLx Pharma Inc., will begin trading on the NASDAQ Capital Market under the symbol “PLXP” on April 20, 2017.